In light of our findings, which demonstrate that bepridil attenuated EMT-like morphological changes and downregulated the expression of vimentin, β-catenin, and Snail, we provide a mechanistic explanation for how bepridil exerts its suppressive effects on ovarian cancer cells, particularly those exhibiting a metastatic phenotype. This evidence concerns the gene VIM and ovarian carcinoma.